Comparison
Magnesium L-Threonate vs Idebenone
Magnesium L-Threonate
MIT-developed magnesium that crosses the blood-brain barrier. Shown to enhance synaptic density and reduce 'brain age'.
Idebenone
Synthetic analog of CoQ10. Crosses the BBB more efficiently than CoQ10 itself. Approved in Europe and Japan for some neurological conditions.
| Field | Magnesium L-Threonate | Idebenone |
|---|---|---|
| Category | neuroprotective | neuroprotective |
| Dose range | 1000–2000mg | 90–270mg |
| Half-life | 6h | — |
| Onset | — | — |
| Evidence | EVIDENCEB | EVIDENCEB |
| Safety | ●●●●● | ●●●●○ |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 90 | 1100 |
The comparison in plain English
Auto-generated from dataMagnesium L-Threonate and Idebenone are both in the neuroprotective category respectively. Magnesium L-Threonate MIT-developed magnesium that crosses the blood-brain barrier. Idebenone Synthetic analog of CoQ10.
Bottom line
Magnesium L-Threonate (evidence B, safety 5/5) matches the evidence base of Idebenone (evidence B, safety 4/5). Magnesium L-Threonate has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose Magnesium L-Threonate if
Magnesium L-Threonate is the better fit when your goal aligns with its mechanism (L-threonate is a sugar-acid carrier that uniquely enables magnesium to cross the blood-brain barrier in meaningful quantities — most oral magnesium forms (oxide, citrate, glycinate) raise serum magnesium but not central magnesium) and the dose range (1000–2000mg) suits your protocol. Half-life is 6h.
Choose Idebenone if
Idebenone is the better fit when your goal aligns with its mechanism (Structural analog of CoQ10 with shorter side chain, producing better water solubility and BBB crossing) and the dose range (90–270mg) suits your protocol. Half-life is —h.